These studies are designed to evaluate the role of the central nervous system in gastric mucosal defensive functions, with respect to neuropeptides and prostaglandins. It is hypothesized that 1) intracerebroventricular (ICV) administration of peptide or prostaglandins which reduce experimental ulceration, do so by enhancing certain aspects of mucosal defense, inhibition of acid secretion, stimulation of bicarbonate and mocus of secretion and maintenance of morosal blood flow. These effects may be mediated by change in gastic monosal prosteplandin activity; 2) that ICV administration of peptides which potentiate experimental ulceration do so by reducing mocosal defense, stimlation of gastric acid secretion, inhibition of gastric bicrbonate and mucus production and reduction in morosal blood flow. Protective compounds given ICV include neurotensin, bombesin, opioids, calcitonin, calcitonin gene related peptide, and prostaglandins E2, T2, and F2. Compounds which potentiate injury, given ICV, include thyrotropin relleasing hormone and vasoactive intestinal polypeptide. Compounds will be given ICV to rats prior to placing them in cold restraint stress or administration of 50% ethanol, acidified aspirin (20 mM) or acidified taurocholate (10mM) orally. The effect of each ICV administered compound will also be studied for its effect on mucosal blood flow measured by hydrogen gas clearance, bicarbonate secretion using a gasometer of pH-stat technique, mucus production measuring the thickness of gel mucus optically and soluble mucus as glucosamine output, and acid secretion by gravity drainage in chronic dogs prepared with a gastric fistula. In addition, the effect of these ICV administered compounds on gastric mucosal prostaglandin activity will be studied using the prostaglandin-generation technique and RIA. These observations should indicate in which instance ICV administered peptides modulate gastric mucosal defensive functions through an endogenous prostaglandin-mediated mechanism. Dose response relationships will be demonstrated. Verification of the central effect will require that peripheral administration of these compounds do not cause similar effects on gastric mucosal functions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK038198-03
Application #
3237463
Study Section
Surgery and Bioengineering Study Section (SB)
Project Start
1987-01-01
Project End
1990-11-30
Budget Start
1989-01-01
Budget End
1990-11-30
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Pennsylvania State University
Department
Type
Schools of Medicine
DUNS #
129348186
City
Hershey
State
PA
Country
United States
Zip Code
17033
Xing, L; Karinch, A M; Kauffman Jr, G L (1998) Mesolimbic expression of neurotensin and neurotensin receptor during stress-induced gastric mucosal injury. Am J Physiol 274:R38-45
Karinch, A M; Schmidt, G L; Kauffman Jr, G L (1998) Pretreatment with SR48692 has different effects on central neurotensin-induced gastric mucosal defense and inhibition of gastric acid secretion in rats. Brain Res 810:123-9
Barocelli, E; Impicciatore, M; Seaton, J et al. (1991) Localization of central prostaglandin E2 antisecretory effects. Gastroenterology 100:320-7
Xing, L P; Balaban, C; Seaton, J et al. (1991) Mesolimbic dopamine mediates gastric mucosal protection by central neurotensin. Am J Physiol 260:G34-8
Saperas, E; Kauffman, G; Tache, Y (1991) Role of central prostaglandin E2 in the regulation of gastric acid secretion in the rat. Eur J Pharmacol 209:1-7
Gunion, M W; Tache, Y (1990) Brain sites where bombesin and corticotropin-releasing factor influence gastric secretions. Ann N Y Acad Sci 597:92-113
Gunion, M W; Kauffman Jr, G L; Tache, Y (1990) Intrahypothalamic corticotropin-releasing factor elevates gastric bicarbonate and inhibits stress ulcers in rats. Am J Physiol 258:G152-7
Xing, L P; Washington, J; Seaton, J et al. (1990) Monoamine oxidase B inhibition reduces gastric mucosal blood flow, basal acid secretion, and cold water restraint-induced gastric mucosal injury in rats. Dig Dis Sci 35:61-5
Xing, L P; King, J C; Bryan, R M et al. (1990) Effect of neurotensin on regional cerebral glucose utilization in cold water-restrained rats. Am J Physiol 258:G591-5
Zhang, L; Xing, L P; Demers, L et al. (1989) Central neurotensin inhibits gastric acid secretion: an adrenergic mechanism in rats. Gastroenterology 97:1130-4

Showing the most recent 10 out of 12 publications